Search results
Results from the WOW.Com Content Network
Compare SGLT-2 inhibitors (sodium-glucose cotransporter-2 inhibitors). View important safety information, ratings, user reviews, popularity and more.
SGLT2 inhibitors are primarily taken to treat Type 2 diabetes. Commonly prescribed drugs on the SGLT2 inhibitors list include Jardiance, Farxiga, and Invokana.
One class of drugs used to control Type 2 diabetes is known as sodium-glucose cotransporter 2 inhibitors, or SGLT2 inhibitors. SGLT2 inhibitors are approved by the U.S. Food and Drug Administration (FDA) to lower blood sugar in adults with Type 2 diabetes mellitus.
There are three types of SGLT2 inhibitors that are currently available: Canagliflozin (marketed as Invokana) Dapagliflozin (marketed as Farxiga) Empagliflozin (marketed as Jardiance) Where? These pills work by preventing glucose from being absorbed in the kidneys. As a result, they decrease glucose in the blood and cause it to spill into the urine.
SGLT2 inhibitors (also called gliflozins or flozins) are a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional units of the kidney), unlike SGLT1 inhibitors that perform a similar function in the intestinal mucosa.
SGLT2 inhibitors are a common treatment for type 2 diabetes. Find out about what medications are available and their benefits and risks.
To date, there are four SGLT-2 inhibitors: canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin that are approved by Food Drug Administration (FDA) for their use in adults.